RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Craniocerebral Trauma
Accession: DOID:9007621
browse the term
Definition: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.
Synonyms: exact_synonym: Craniocerebral Injuries; Craniocerebral Injury; Craniocerebral Traumas; Crushing Skull Injuries; Crushing Skull Injury; Forehead Trauma; Forehead Traumas; Frontal Region Trauma; Frontal Region Traumas; Head Injuries; Head Injury; Head Trauma; Head Traumas; Minor Head Injuries; Minor Head Injury; Multiple Head Injuries; Multiple Head Injury; Occipital Region Trauma; Occipital Region Traumas; Occipital Trauma; Occipital Traumas; Open Head Injuries; Open Head Injury; Parietal Region Trauma; Parietal Region Traumas; Superficial Head Injuries; Superficial Head Injury; Temporal Region Trauma; Temporal Region Traumas
primary_id: MESH:D006259 ; RDO:0005059
xref: EFO:0009505
G
ADNP
activity dependent neuroprotector homeobox
ISO
RGD
PMID:11123362
RGD:2312784
NCBI chr20:50,888,918...50,931,437
Ensembl chr20:50,888,916...50,931,437
G
IL1A
interleukin 1 alpha
IEP
protein:increased expression:microglial cell
RGD
PMID:7830934
RGD:10045949
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
POSTN
periostin
ISO
RGD
PMID:17878602
RGD:10041014
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
G
SERPINC1
serpin family C member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8810955
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
EPO
erythropoietin
treatment
IDA
RGD
PMID:23415790
RGD:10401075
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
F7
coagulation factor VII
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12503044
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
KCNN4
potassium calcium-activated channel subfamily N member 4
treatment
ISO
RGD
PMID:15379997
RGD:329969897
NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976
G
CFL1
cofilin 1
treatment
IEP
RGD
PMID:25708984
RGD:12738361
NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DRD3
dopamine receptor D3
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 3:114,127,580...114,199,407
Ensembl chr 3:114,127,580...114,199,407
G
DRD4
dopamine receptor D4
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr11:637,269...640,706
Ensembl chr11:637,269...640,706
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:27113205
RGD:11062140
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
C3
complement C3
ameliorates
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
IL1B
interleukin 1 beta
treatment
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
PYCARD
PYD and CARD domain containing
treatment
ISO
RGD
PMID:19401709
RGD:5491174
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ABCC8
ATP binding cassette subfamily C member 8
treatment
ISO
RGD
PMID:21107131
RGD:12791995
NCBI chr11:17,392,498...17,476,845
Ensembl chr11:17,392,498...17,476,894
G
ACAN
aggrecan
ISO
mRNA:increased expression:fascia dentata (rat)
RGD
PMID:18511192
RGD:2315807
NCBI chr15:88,803,436...88,875,353
Ensembl chr15:88,803,436...88,875,353
G
ACTR2
actin related protein 2
ISO
mRNA, protein:decreased expression:hippocampus (rat)
RGD
PMID:22120305
RGD:11530046
NCBI chr 2:65,227,831...65,271,253
Ensembl chr 2:65,227,788...65,271,253
G
ADCYAP1
adenylate cyclase activating polypeptide 1
ISO
RGD
PMID:16689670
RGD:2325298
NCBI chr18:904,411...912,172
Ensembl chr18:904,871...912,172
G
ADRA1A
adrenoceptor alpha 1A
ISO
mRNA:increased expression:frontal cortex
RGD
PMID:20974230
RGD:5688366
NCBI chr 8:26,748,150...26,867,379
Ensembl chr 8:26,748,150...26,867,278
G
AGER
advanced glycosylation end-product specific receptor
ISO
protein:increased expression:brain (rat)
RGD
PMID:22915134 PMID:24859607 PMID:22491548
RGD:7245513 , RGD:8696001 , RGD:7245557
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AIF1
allograft inflammatory factor 1
ISO
protein:increased expression:cerebral cortex (rat)
RGD
PMID:19520144
RGD:2313020
NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021
G
AIFM1
apoptosis inducing factor mitochondria associated 1
ISO
protein:increased expression:nucleus:
RGD
PMID:12091479
RGD:10053567
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
G
AKT1
AKT serine/threonine kinase 1
IEP
protein:increased phosphorylation:brain, neuron
RGD
PMID:16234845
RGD:5509090
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
ALB
albumin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:7909931 PMID:17188501
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
AMBP
alpha-1-microglobulin/bikunin precursor
IEP
protein:increased expression:urine
RGD
PMID:14592616
RGD:6904155
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
G
ANK3
ankyrin 3
ISO
RGD
PMID:20557305
RGD:6767288
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
ANP32A
acidic nuclear phosphoprotein 32 family member A
ISO
RGD
PMID:24385964
RGD:10401136
NCBI chr15:68,778,535...68,820,895
Ensembl chr15:68,778,535...68,820,897
G
APAF1
apoptotic peptidase activating factor 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:11567033
RGD:2325751
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
G
APBB1
amyloid beta precursor protein binding family B member 1
ISO
mRNA:increased expression:brain
RGD
PMID:12707777
RGD:2301208
NCBI chr11:6,395,124...6,419,453
Ensembl chr11:6,395,125...6,419,414
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11447995
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
G
APOD
apolipoprotein D
ISO
mRNA, protein:increased expression:cerebral cortex, glia cell, neuron
RGD
PMID:10501208
RGD:2311202
NCBI chr 3:195,568,705...195,583,940
Ensembl chr 3:195,568,705...195,584,033
G
APOE
apolipoprotein E
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
APP
amyloid beta precursor protein
IEP
protein:increased expression:hippocampus
RGD
PMID:16300758
RGD:10054281
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
AQP4
aquaporin 4
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21083433 PMID:21488209
RGD:5148014 , RGD:5148034
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
ASIC1
acid sensing ion channel subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21307247
NCBI chr12:50,057,596...50,083,622
Ensembl chr12:50,057,548...50,083,611
G
ASTN1
astrotactin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr 1:176,857,321...177,164,712
Ensembl chr 1:176,857,302...177,164,973
G
ATG12
autophagy related 12
ISO
protein:altered localization:brain
RGD
PMID:18059433
RGD:2301217
NCBI chr 5:115,828,200...115,841,565
Ensembl chr 5:115,828,200...115,841,837
G
ATP5PD
ATP synthase peripheral stalk subunit d
treatment
ISO
RGD
PMID:26813465
RGD:13800884
NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985
G
AVPR1A
arginine vasopressin receptor 1A
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:17244947
RGD:2300372
NCBI chr12:63,142,759...63,151,201
Ensembl chr12:63,142,759...63,151,201
G
BAD
BCL2 associated agonist of cell death
ISO
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:15941375
RGD:2292694
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCAT1
branched chain amino acid transaminase 1
ISO
Protein:increased expression:neurons
RGD
PMID:10686349
RGD:631308
NCBI chr12:24,810,024...24,949,340
Ensembl chr12:24,810,024...24,949,101
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:18093155 PMID:20888848
RGD:2293059 , RGD:10054247
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BDNF
brain derived neurotrophic factor
IEP EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15500971 PMID:21269288 PMID:20544832
RGD:4891136
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BECN1
beclin 1
ISO EXP
protein:increased expression:neuron, astrocyte CTD Direct Evidence: therapeutic protein:increased expression:hippocampus protein:increased expression:brain
CTD RGD
PMID:34929507 PMID:18500386 PMID:24221859 PMID:16874043
RGD:6483098 , RGD:11558018 , RGD:6483314
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
BIRC5
baculoviral IAP repeat containing 5
ISO
mRNA, protein:increased expression:brain, astrocyte, neuron
RGD
PMID:15453988
RGD:2293136
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BMP6
bone morphogenetic protein 6
ISO
protein:increased expression:brain, astrocyte, neuron
RGD
PMID:16388909
RGD:2289020
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
G
BMPR2
bone morphogenetic protein receptor type 2
ISO
mRNA:increased expression:dentate gyrus, neuron
RGD
PMID:9080432
RGD:5129488
NCBI chr 2:202,376,327...202,567,749
Ensembl chr 2:202,376,327...202,567,751
G
BYSL
bystin like
ISO
mRNA, protein:increased expression:substantia nigra, striatum (rat)
RGD
PMID:15305856
RGD:2316201
NCBI chr 6:41,908,759...41,933,046
Ensembl chr 6:41,921,229...41,933,050
G
C1QA
complement C1q A chain
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr 1:22,636,463...22,639,678
Ensembl chr 1:22,635,077...22,639,678
G
C3
complement C3
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CASK
calcium/calmodulin dependent serine protein kinase
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr X:41,514,934...41,923,554
Ensembl chr X:41,514,934...41,923,554
G
CASP1
caspase 1
ISO
mRNA, protein:increased expression:brain
RGD
PMID:17188500
RGD:2315917
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CASP12
caspase 12 (gene/pseudogene)
severity
ISO
mRNA, protein:increased expression, increased activity:cerebral cortex, hippocampus, neuron, astrocyte
RGD
PMID:14675152
RGD:2311485
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP8
caspase 8
ISO
protein:altered localization
RGD
PMID:15590916
RGD:1624191
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CAST
calpastatin
severity
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:15307896
RGD:5509821
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,247,756...96,779,595 Ensembl chr 5:96,247,756...96,779,595
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO EXP
protein:increased expression:brain, neuron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:19210118 PMID:11113322
RGD:2306999 , RGD:9587789
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:22040257
RGD:7483630
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:hippocampus
RGD
PMID:24344922
RGD:8552265
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD14
CD14 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:23924471
RGD:7248749
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD40LG
CD40 ligand
treatment
ISO
RGD
PMID:11755016 PMID:25972624
RGD:8547803 , RGD:11344972
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:nucleus:
RGD
PMID:9914434
RGD:8662346
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
protein:decreased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
mRNA, protein:increased expression:cerebral cortex (mouse)
RGD
PMID:19833158
RGD:10401206
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
G
CEBPB
CCAAT enhancer binding protein beta
ISO EXP
mRNA, protein:increased expression:cerebral cortex (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:19833158
RGD:10401206
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,734...50,192,690
G
CES1
carboxylesterase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CFB
complement factor B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17474994
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,086
G
CHRM2
cholinergic receptor muscarinic 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:136,868,652...137,020,213
Ensembl chr 7:136,868,652...137,020,255
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr15:32,030,483...32,173,018
Ensembl chr15:31,923,438...32,173,018
G
CKMT1B
creatine kinase, mitochondrial 1B
treatment
ISO
RGD
PMID:24252176
RGD:11565089
NCBI chr15:43,592,857...43,599,406
Ensembl chr15:43,593,054...43,604,901 Ensembl chr15:43,593,054...43,604,901
G
CLEC4E
C-type lectin domain family 4 member E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr12:8,533,275...8,540,905
Ensembl chr12:8,533,305...8,540,905
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
protein:increased expression:hippocampus
RGD
PMID:20215974
RGD:6483336
NCBI chr17:41,966,795...41,977,740
Ensembl chr17:41,966,763...41,977,740
G
COMT
catechol-O-methyltransferase
ISO
protein:increased expression:hippocampus
RGD
PMID:17240060
RGD:2289740
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
CRP
C-reactive protein
disease_progression
IEP
RGD
PMID:24456846
RGD:9585646
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CSF2
colony stimulating factor 2
disease_progression
ISO
RGD
PMID:21515263
RGD:5686795
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSF3
colony stimulating factor 3
treatment
IDA EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:24239694
RGD:11039431
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
protein:altered expression:cerebral cortex
RGD
PMID:19473238
RGD:5686860
NCBI chr15:75,674,322...75,713,466
Ensembl chr15:75,674,322...75,712,848
G
CUL5
cullin 5
ISO
mRNA, protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17010517
RGD:2301432
NCBI chr11:108,008,898...108,107,761
Ensembl chr11:108,008,898...108,107,761
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
mRNA:increased expression:choroid plexus, cerebral cortex
RGD
PMID:19471279
RGD:5135009
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
protein:increased expression:brain, neuron
RGD
PMID:19210118
RGD:2306999
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
ISO
mRNA:increased expression:hindbrain
RGD
PMID:16329132
RGD:1599699
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
G
CYP4F12
cytochrome P450 family 4 subfamily F member 12
ISO
RGD
PMID:18847377
RGD:2301705
NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
G
DAB2
DAB adaptor protein 2
ISO
RGD
PMID:15774263
RGD:7243841
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
G
DNMT1
DNA methyltransferase 1
ISO
RGD
PMID:19429151
RGD:9588608
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DPYSL2
dihydropyrimidinase like 2
ISO
protein:increased degradation:cerebral cortex, hippocampus
RGD
PMID:17402852
RGD:2303056
NCBI chr 8:26,514,031...26,658,175
Ensembl chr 8:26,514,031...26,658,178
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:18509630
RGD:2311580
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DUSP5
dual specificity phosphatase 5
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:12503083
RGD:2317873
NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
G
EIF3E
eukaryotic translation initiation factor 3 subunit E
treatment
ISO
RGD
PMID:22960363
RGD:10395371
NCBI chr 8:108,201,216...108,248,717
Ensembl chr 8:108,162,787...108,443,496
G
ELK1
ETS transcription factor ELK1
ISO
RGD
PMID:15362724
RGD:7488910
NCBI chr X:47,635,520...47,650,604
Ensembl chr X:47,635,520...47,650,604
G
ENO2
enolase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34533065
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
EPAS1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:22960363
RGD:10395371
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
G
EPHA4
EPH receptor A4
IEP
protein:increased expression, increased activity:astrocyte
RGD
PMID:22318127
RGD:5688763
NCBI chr 2:221,418,027...221,574,202
Ensembl chr 2:221,418,027...221,574,202
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:21075124
RGD:5688356
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
EPO
erythropoietin
treatment
IDA EXP ISO
CTD Direct Evidence: therapeutic mRNA:increased expression:brain:
CTD RGD
PMID:20833152 PMID:23063952 PMID:18093155
RGD:10401061 , RGD:2293059
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
EPOR
erythropoietin receptor
ISO
mRNA:increased expression:brain:
RGD
PMID:18093155
RGD:2293059
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
G
F2
coagulation factor II, thrombin
severity
IDA
RGD
PMID:21355766
RGD:5147766
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
FAS
Fas cell surface death receptor
ISO
mRNA:increased expression:hippocampus associated with Hyperoxia
RGD
PMID:16078565 PMID:19107989
RGD:1600354 , RGD:8662854
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FGF2
fibroblast growth factor 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21269288
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FMR1
fragile X messenger ribonucleoprotein 1
ISO
protein:altered localization:hippocampus (rat)
RGD
PMID:16510718
RGD:11667962
NCBI chr X:147,911,919...147,951,125
Ensembl chr X:147,911,919...147,951,125
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9630518
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
G
FOXP1
forkhead box P1
treatment
ISO
RGD
PMID:26842647
RGD:11561903
NCBI chr 3:70,954,708...71,583,978
Ensembl chr 3:70,954,693...71,583,978
G
G6PD
glucose-6-phosphate dehydrogenase
ISO
protein:decreased expression:hippocampus
RGD
PMID:18501200
RGD:2307353
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
G
GABRG3
gamma-aminobutyric acid type A receptor subunit gamma3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr15:26,971,181...27,541,984
Ensembl chr15:26,971,181...27,541,984
G
GDNF
glial cell derived neurotrophic factor
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GJA1
gap junction protein alpha 1
treatment
ISO
RGD
PMID:23485053
RGD:8662424
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GJA5
gap junction protein alpha 5
ISO
protein:increased expression:cerebral artery
RGD
PMID:21895483
RGD:7207391
NCBI chr 1:147,756,199...147,773,351
Ensembl chr 1:147,756,199...147,773,362
G
GPX1
glutathione peroxidase 1
ISO
mRNA:decreased expression:hippocampus, neuron
RGD
PMID:15791111
RGD:2306624
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GRM8
glutamate metabotropic receptor 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:126,438,598...127,252,941
Ensembl chr 7:126,438,598...127,253,093
G
GSK3B
glycogen synthase kinase 3 beta
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24675465 PMID:22643085
RGD:10045646
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSN
gelsolin
ISO
RGD
PMID:14588109
RGD:1599864
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
HCN1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
mRNA,protein:decreased expression:hippocampus:
RGD
PMID:11726545
RGD:9686434
NCBI chr 5:45,254,948...45,696,380
Ensembl chr 5:45,254,948...45,696,498
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:22915134
RGD:7245513
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:18562561
RGD:5508455
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:23470432
RGD:10755702
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HP
haptoglobin
ISO
mRNA:increased expression:liver
RGD
PMID:23172820
RGD:11041806
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
ISO EXP
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:21549006
RGD:5147593
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:cerebral white matter (rat)
RGD
PMID:22067617
RGD:5688785
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
G
HSPB1
heat shock protein family B (small) member 1
ISO
RGD
PMID:11746764
RGD:6480530
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813
G
HTR7
5-hydroxytryptamine receptor 7
ISO
RGD
PMID:22465320
RGD:6482178
NCBI chr10:90,740,823...90,858,039
Ensembl chr10:90,740,823...90,858,039
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:brain:
RGD
PMID:16230799
RGD:11522716
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNL3
interferon lambda 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr19:39,243,455...39,245,250
Ensembl chr19:39,243,455...39,245,250
G
IGF1
insulin like growth factor 1
treatment
IDA
human protein in a rat model
RGD
PMID:9344566
RGD:12904928
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF2
insulin like growth factor 2
ISO
mRNA:decreased expression:brain
RGD
PMID:11123717
RGD:5509972
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
IL10
interleukin 10
severity treatment
IEP EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:23075771 PMID:23971414
RGD:7364822 , RGD:7364983
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12RB2
interleukin 12 receptor subunit beta 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 1:67,307,364...67,398,724
Ensembl chr 1:67,307,364...67,398,724
G
IL13RA2
interleukin 13 receptor subunit alpha 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
G
IL16
interleukin 16
ISO
RGD
PMID:17983426
RGD:5024939
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
G
IL17RD
interleukin 17 receptor D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:57,089,982...57,170,317
Ensembl chr 3:57,089,982...57,170,306
G
IL18
interleukin 18
severity
ISO
mRNA, protein:increased expression:brain
RGD
PMID:17188500 PMID:17188500
RGD:2315917 , RGD:2315917
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
G
IL18R1
interleukin 18 receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 2:102,355,796...102,398,776
Ensembl chr 2:102,311,529...102,398,777
G
IL1A
interleukin 1 alpha
ISO EXP
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:16024175
RGD:2311098
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
ISO EXP
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism protein:increased expression:brain, cerebrospinal fluid mRNA, protein:increased expression:brain
CTD RGD
PMID:19800810 PMID:21549006 PMID:16024175 PMID:22503903 PMID:17612572
RGD:2311098 , RGD:6482651 , RGD:1626652
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R1
interleukin 1 receptor type 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
G
IL1RN
interleukin 1 receptor antagonist
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:25665855
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL3
interleukin 3
disease_progression
ISO IEP
protein: increased expression: brain: microdialysis perfusate
RGD
PMID:21515263 PMID:20717122
RGD:5686795 , RGD:5686886
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
G
IL31RA
interleukin 31 receptor A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 5:55,839,789...55,922,850
Ensembl chr 5:55,851,357...55,922,854
G
IL4
interleukin 4
ISO
protein:decreased expression:plasma
RGD
PMID:24519543
RGD:10402802
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL5
interleukin 5
treatment
ISO
RGD
PMID:24602693 PMID:24530657
RGD:11522766 , RGD:11522770
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IL6
interleukin 6
ISO EXP
protein:increased expression:cerebrospinal fluid (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19800810 PMID:21549006 PMID:23159883 PMID:10027774
RGD:11049549
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL7
interleukin 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
G
IL9R
interleukin 9 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr X:155,997,696...156,013,020 NCBI chr Y:57,184,072...57,197,869
Ensembl chr X:155,997,696...156,013,017 Ensembl chr Y:155,997,696...156,013,017
G
IRF1
interferon regulatory factor 1
ISO EXP
mRNA:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:12503083
RGD:2317873
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
JAK2
Janus kinase 2
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
RGD
PMID:20861444
RGD:8662901
NCBI chr 1:160,037,467...160,070,160
Ensembl chr 1:159,998,651...160,070,483
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21307798 PMID:19733172
RGD:5684382 , RGD:5684402
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
LEP
leptin
ISO
RGD
PMID:21276361
RGD:5128517
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LSG1
large 60S subunit nuclear export GTPase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr 3:194,640,791...194,672,191
Ensembl chr 3:194,640,791...194,672,463
G
LY86
lymphocyte antigen 86
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 6:6,588,720...6,654,982
Ensembl chr 6:6,588,108...6,654,983
G
MAG
myelin associated glycoprotein
susceptibility
ISO
RGD
PMID:17156367
RGD:9685230
NCBI chr19:35,292,161...35,313,807
Ensembl chr19:35,292,125...35,313,807
G
MAP1B
microtubule associated protein 1B
ISO
protein:increased expression, increased phosphorylation:brain
RGD
PMID:10906717
RGD:2304029
NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
ISO
RGD
PMID:24221859
RGD:11558018
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
G
MAP2
microtubule associated protein 2
ISO
protein:decreased expression:cerebral cortex, neuron
RGD
PMID:21401443 PMID:20568963
RGD:6483087 , RGD:6483089
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO
associated with Subarachnoid Hemorrhage
RGD
PMID:27000704 PMID:33414375 PMID:26100626
RGD:155791672 , RGD:155882440 , RGD:155804286
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MBL2
mannose binding lectin 2
disease_progression
ISO
RGD
PMID:18183030
RGD:12910935
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MBP
myelin basic protein
ISO
RGD
PMID:18583256
RGD:7349333
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
G
MDM2
MDM2 proto-oncogene
ISO
protein:increased expression:brain cortex (rat)
RGD
PMID:15165363
RGD:2317397
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
MIF
macrophage migration inhibitory factor
ISO
RGD
PMID:15922484
RGD:1641989
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR132
microRNA 132
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr17:2,049,908...2,050,008
Ensembl chr17:2,049,908...2,050,008
G
MIR144
microRNA 144
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr17:28,861,533...28,861,618
Ensembl chr17:28,861,533...28,861,618
G
MIR153-2
microRNA 153-2
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr 7:157,574,336...157,574,422
Ensembl chr 7:157,574,336...157,574,422
G
MIR183
microRNA 183
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:129,774,905...129,775,014
Ensembl chr 7:129,774,905...129,775,014
G
MMP9
matrix metallopeptidase 9
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19631748 PMID:16671440 PMID:24661104
RGD:1582656 , RGD:13207312
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MT-CO2
mitochondrially encoded cytochrome c oxidase II
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:11686499
RGD:2302298
NCBI chr MT:7,586...8,269
Ensembl chr MT:7,586...8,269
G
MT2A
metallothionein 2A
ISO
mRNA:increased expression:liver (mouse) mRNA:increased expression:dentate gyrus (rat)
RGD
PMID:22363575 PMID:15650329
RGD:6483812 , RGD:6483847
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
G
MT3
metallothionein 3
treatment
ISO
RGD
PMID:16314047 PMID:10595827 PMID:10218634
RGD:6480628 , RGD:9685805 , RGD:9685803
NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088
G
MYOC
myocilin
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12799138
RGD:7401267
NCBI chr 1:171,635,417...171,652,688
Ensembl chr 1:171,635,417...171,652,688
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
protein:increased expression:lung:
RGD
PMID:18787991 PMID:25089700
RGD:5134971 , RGD:11576302
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NGB
neuroglobin
severity
ISO
RGD
PMID:21915648
RGD:9743963
NCBI chr14:77,265,483...77,271,206
Ensembl chr14:77,265,483...77,271,206
G
NGFR
nerve growth factor receptor
treatment
ISO
RGD
PMID:23940017
RGD:10414074
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOX4
NADPH oxidase 4
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:36762617
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
G
NPPB
natriuretic peptide B
IEP EXP
associated with lung diseases;protein:increased expression:serum: CTD Direct Evidence: therapeutic
CTD RGD
PMID:19803787 PMID:23837838
RGD:7247620
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
G
NPY
neuropeptide Y
ISO
protein:increased expression:adrenal medulla
RGD
PMID:23570732
RGD:10448961
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
mRNA:increased expression:lung associated with Subarachnoid Hemorrhage
RGD
PMID:18787991 PMID:20864352
RGD:5134971 , RGD:11035222
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NT5E
5'-nucleotidase ecto
ISO
protein:altered expression:cerebral cortex (rat)
RGD
PMID:21337375
RGD:5134348
NCBI chr 6:85,450,083...85,495,784
Ensembl chr 6:85,449,584...85,495,791
G
P2RY1
purinergic receptor P2Y1
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:19115395
RGD:2315811
NCBI chr 3:152,835,131...152,841,439
Ensembl chr 3:152,835,131...152,841,439
G
PALLD
palladin, cytoskeletal associated protein
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:12932445
RGD:2325786
NCBI chr 4:168,497,052...168,928,441
Ensembl chr 4:168,497,052...168,928,457
G
PARP1
poly(ADP-ribose) polymerase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17640816
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA,protein:increased expression:brain:
RGD
PMID:11421591
RGD:9835358
NCBI chr12:79,584,879...79,690,964
Ensembl chr12:79,574,979...79,690,964
G
PDE4D
phosphodiesterase 4D
ISO
mRNA, protein:alternative form, decreased phosphorylation:brain
RGD
PMID:23057870
RGD:7327147
NCBI chr 5:58,969,038...60,522,128
Ensembl chr 5:58,969,038...60,522,120
G
PDGFA
platelet derived growth factor subunit A
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
G
PDGFB
platelet derived growth factor subunit B
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PDGFRA
platelet derived growth factor receptor alpha
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245
G
PDGFRB
platelet derived growth factor receptor beta
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
RGD
PMID:22658532
RGD:6484732
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PGLYRP1
peptidoglycan recognition protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr19:46,019,153...46,023,053
Ensembl chr19:46,019,153...46,023,053
G
PGR
progesterone receptor
ISO
RGD
PMID:23211561
RGD:7248711
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
PHB1
prohibitin 1
ISO
protein:increased oxidation:cerebral cortex
RGD
PMID:17518533
RGD:2292409
NCBI chr17:49,404,052...49,414,882
Ensembl chr17:49,404,049...49,414,905
G
PHB2
prohibitin 2
ISO
RGD
PMID:24566151
RGD:12903261
NCBI chr12:6,965,327...6,970,753
Ensembl chr12:6,965,327...6,970,780
G
PIAS1
protein inhibitor of activated STAT 1
ISO
protein:decreased expression:brain, nucleus
RGD
PMID:21545521
RGD:8693413
NCBI chr15:68,054,315...68,193,847
Ensembl chr15:68,054,309...68,198,603
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
agonist more effective in combination with simvastatin (rat)
RGD
PMID:18562561
RGD:5508455
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARGC1A
PPARG coactivator 1 alpha
treatment
ISO
protein:decreased expression:frontal cortex (rat)
RGD
PMID:22642418 PMID:24345766
RGD:6484257 , RGD:10059630
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
ISO EXP
protein: :hippocampus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14499481 PMID:19751097
RGD:6483311
NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278
G
PRF1
perforin 1
IEP
RGD
PMID:20537642
RGD:6482807
NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759
G
PTGER3
prostaglandin E receptor 3
ISO
protein:increased expression:striatum, microglia (rat)
RGD
PMID:15234107
RGD:9850280
NCBI chr 1:70,852,358...71,047,816
Ensembl chr 1:70,852,353...71,047,816
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO IEP
protein:increased expression:microglia, macrophage protein:increased expression:microglial cells, macrophage, endothelial cell
RGD
PMID:19719848 PMID:11565600 PMID:12005397
RGD:5688162 , RGD:5688242 , RGD:5688239
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12410334 PMID:20810888 PMID:21549006 PMID:21866634 PMID:19719848
RGD:5508191 , RGD:5688162
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTPRZ1
protein tyrosine phosphatase receptor type Z1
ISO
RGD
PMID:12088737
RGD:727637
NCBI chr 7:121,873,161...122,062,036
Ensembl chr 7:121,873,089...122,062,036
G
RCHY1
ring finger and CHY zinc finger domain containing 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr 4:75,479,033...75,514,715
Ensembl chr 4:75,479,033...75,514,764
G
REG3A
regenerating family member 3 alpha
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:19351265
RGD:9831399
NCBI chr 2:79,157,006...79,159,753
Ensembl chr 2:79,157,003...79,159,753
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:ileum
RGD
PMID:18288455
RGD:2298787
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr10:43,077,069...43,130,351
Ensembl chr10:43,077,064...43,130,351
G
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17929039
RGD:2298888
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
ROBO1
roundabout guidance receptor 1
ISO
mRNA:increased expression:brain protein:increased expression:brain, immune cell
RGD
PMID:16262652 PMID:26550694
RGD:2316136 , RGD:243048437
NCBI chr 3:78,597,239...79,767,998
Ensembl chr 3:78,597,239...79,767,998
G
ROBO2
roundabout guidance receptor 2
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr 3:75,906,675...77,649,964
Ensembl chr 3:75,906,695...77,649,964
G
ROBO3
roundabout guidance receptor 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr11:124,865,432...124,881,471
Ensembl chr11:124,865,432...124,881,471
G
RPS27A
ribosomal protein S27a
ISO
mRNA:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17936732
RGD:11041870
NCBI chr 2:55,231,903...55,235,853
Ensembl chr 2:55,231,903...55,235,853
G
S100B
S100 calcium binding protein B
severity
IEP EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:11520488 PMID:21783483 PMID:21976236
RGD:5508761
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
SELE
selectin E
ISO
protein:increased expression:brain
RGD
PMID:19107536
RGD:2313599
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
G
SERPINC1
serpin family C member 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21534203
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPINF1
serpin family F member 1
treatment
IMP ISO
human gene in a rat model protein:altered expression:cerebellum (rat)
RGD
PMID:20142768 PMID:17709187
RGD:8612994 , RGD:8622925
NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:17970622
RGD:9497541
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SKP2
S-phase kinase associated protein 2
ISO
protein:increased expression:brain
RGD
PMID:19852587
RGD:2315049
NCBI chr 5:36,152,111...36,193,530
Ensembl chr 5:36,151,989...36,196,849
G
SLC18A3
solute carrier family 18 member A3
ISO
protein:decreased expression:brain
RGD
PMID:18848922
RGD:5686682
NCBI chr10:49,610,310...49,612,720
Ensembl chr10:49,610,310...49,612,720
G
SLIT1
slit guidance ligand 1
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr10:96,998,038...97,185,959
Ensembl chr10:96,998,038...97,185,959
G
SLIT2
slit guidance ligand 2
exacerbates
ISO
RGD
PMID:26550694
RGD:243048437
NCBI chr 4:20,251,905...20,620,561
Ensembl chr 4:20,251,905...20,620,561
G
SLIT3
slit guidance ligand 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr 5:168,661,740...169,301,139
Ensembl chr 5:168,661,740...169,301,139
G
SNCA
synuclein alpha
ISO
RGD
PMID:14637093 PMID:25089700
RGD:6480195 , RGD:11576302
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
G
SNCB
synuclein beta
ISO
RGD
PMID:14637093
RGD:6480195
NCBI chr 5:176,620,082...176,630,534
Ensembl chr 5:176,620,082...176,630,556
G
SNCG
synuclein gamma
ISO
RGD
PMID:14637093
RGD:6480195
NCBI chr10:86,955,759...86,963,258
Ensembl chr10:86,958,599...86,963,258
G
SNW1
SNW domain containing 1
ISO
mRNA, protein:increased expression:cerebral cortex (rat)
RGD
PMID:22965216
RGD:11035237
NCBI chr14:77,717,599...77,761,156
Ensembl chr14:77,717,599...77,761,207
G
SOD1
superoxide dismutase 1
ISO
RGD
PMID:16248885
RGD:1581214
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
ISO EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:24462953 PMID:16248885
RGD:1581214
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA:increased expression:brain, blood vessel
RGD
PMID:9704602
RGD:2300066
NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
G
SSTR2
somatostatin receptor 2
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr17:73,165,010...73,176,633
Ensembl chr17:73,165,010...73,176,633
G
SSTR3
somatostatin receptor 3
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr22:37,204,237...37,220,548
Ensembl chr22:37,204,237...37,212,477
G
SSTR4
somatostatin receptor 4
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr20:23,035,312...23,039,237
Ensembl chr20:23,035,312...23,039,237
G
STAT1
signal transducer and activator of transcription 1
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
STAT3
signal transducer and activator of transcription 3
ISO
protein:increased phosphorylation:brain
RGD
PMID:21596098 PMID:22145815 PMID:22827467
RGD:6483023 , RGD:8694312 , RGD:6892706
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STRN
striatin
ISO
RGD
PMID:16351572
RGD:2311293
NCBI chr 2:36,837,698...36,966,536
Ensembl chr 2:36,837,698...36,966,536
G
TARDBP
TAR DNA binding protein
IEP
RGD
PMID:22101322
RGD:5687195
NCBI chr 1:11,012,654...11,030,528
Ensembl chr 1:11,012,344...11,030,528
G
TF
transferrin
ISO
RGD
PMID:22538758
RGD:7244386
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
G
TH
tyrosine hydroxylase
ISO
protein:decreased activity:striatum (rat)
RGD
PMID:21047500
RGD:5128822
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
G
THBD
thrombomodulin
onset
IEP
RGD
PMID:17895610
RGD:5685007
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TICAM2
TIR domain containing adaptor molecule 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 5:115,578,496...115,602,479
Ensembl chr 5:115,578,496...115,602,479
G
TIMP1
TIMP metallopeptidase inhibitor 1
ISO
mRNA:increased expression:brain, astrocytes
RGD
PMID:10719361
RGD:2290468
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TIMP2
TIMP metallopeptidase inhibitor 2
ISO
mRNA:increased expression:brain, neuron, microglial cell
RGD
PMID:10719361
RGD:2290468
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TJP1
tight junction protein 1
ISO
RGD
PMID:19889224
RGD:2325128
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
G
TLR1
toll like receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,787,555...38,856,817
G
TLR2
toll like receptor 2
ISO EXP
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:18316784
RGD:2312713
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
TLR4
toll like receptor 4
ISO EXP
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:18316784
RGD:2312713
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR9
toll like receptor 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNF
tumor necrosis factor
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19800810 PMID:21549006 PMID:10674461
RGD:13825262
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF13B
TNF receptor superfamily member 13B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr17:16,939,081...16,972,118
Ensembl chr17:16,929,816...16,972,118
G
TNFRSF13C
TNF receptor superfamily member 13C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr22:41,922,032...41,926,806
Ensembl chr22:41,922,032...41,926,806
G
TNFRSF14
TNF receptor superfamily member 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 1:2,554,234...2,563,829
Ensembl chr 1:2,555,639...2,565,382
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO EXP
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:17074049
RGD:1624183
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFSF10
TNF superfamily member 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TNFSF12
TNF superfamily member 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr17:7,549,058...7,557,881
Ensembl chr17:7,548,508...7,557,890
G
TRAF4
TNF receptor associated factor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr17:28,744,011...28,750,956
Ensembl chr17:28,744,011...28,750,956
G
TRPM2
transient receptor potential cation channel subfamily M member 2
ISO
mRNA, protein:increased expression:cerebral cortex, hippocampus
RGD
PMID:20309649
RGD:9999437
NCBI chr21:44,353,621...44,442,644
Ensembl chr21:44,350,163...44,443,081
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
ISO
mRNA:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:17936732
RGD:11041870
NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
G
UCP2
uncoupling protein 2
IMP EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12858170 PMID:12858170
RGD:7204436
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,061...73,982,843
G
VEGFA
vascular endothelial growth factor A
ISO EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:18065154 PMID:12230324
RGD:1580574
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFB
vascular endothelial growth factor B
ISO
mRNA, protein:increased expression:brain
RGD
PMID:12230324
RGD:1580574
NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264
G
VIM
vimentin
ISO
protein:increased expression:brain
RGD
PMID:19728994 PMID:15527750
RGD:6480519 , RGD:6480527
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
XDH
xanthine dehydrogenase
treatment
ISO
RGD
PMID:26528358
RGD:13208950
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
G
APOE
apolipoprotein E
susceptibility
IAGP
DNA:polymorphism:exon:
RGD
PMID:9214529
RGD:7495763
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
TARDBP
TAR DNA binding protein
IEP
protein:increased expression:brain
RGD
PMID:20720505
RGD:5687179
NCBI chr 1:11,012,654...11,030,528
Ensembl chr 1:11,012,344...11,030,528
G
BECN1
beclin 1
ISO
protein:increased expression:neuron
RGD
PMID:16004578
RGD:6483315
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
GFAP
glial fibrillary acidic protein
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
G
GOT1
glutamic-oxaloacetic transaminase 1
IDA
human protein in a rat model
RGD
PMID:17014847
RGD:13504858
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
IGF1
insulin like growth factor 1
IEP
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGFBP3
insulin like growth factor binding protein 3
IEP
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
VIM
vimentin
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
ALDH3A1
aldehyde dehydrogenase 3 family member A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28038895
NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943
G
TP63
tumor protein p63
ISO
RGD
PMID:12167247
RGD:11568649
NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
G
IFNG
interferon gamma
ISO
mRNA,protein:increased expression:corneal
RGD
PMID:15832292
RGD:8157597
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
BMP4
bone morphogenetic protein 4
ISO
mRNA:increased expression:superior cervical ganglion
RGD
PMID:16420416
RGD:2289006
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:15153618
RGD:4891994
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
S100B
S100 calcium binding protein B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30076900
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:22553604
RGD:7364851
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:retina
RGD
PMID:9618720
RGD:7794723
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:cornea, neutrophil, macrophage (rat)
RGD
PMID:24194635
RGD:8552904
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
FGF2
fibroblast growth factor 2
ISO
protein:increased expression:lens
RGD
PMID:15273655 PMID:15273655
RGD:8655664 , RGD:8655664
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
MIR182
microRNA 182
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr 7:129,770,383...129,770,492
Ensembl chr 7:129,770,383...129,770,492
G
MIR183
microRNA 183
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr 7:129,774,905...129,775,014
Ensembl chr 7:129,774,905...129,775,014
G
MIR96
microRNA 96
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr 7:129,774,692...129,774,769
Ensembl chr 7:129,774,692...129,774,769
G
PPARG
peroxisome proliferator activated receptor gamma
treatment
ISO
RGD
PMID:18658087
RGD:8552893
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
ADCYAP1
adenylate cyclase activating polypeptide 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:19427307
RGD:2325258
NCBI chr18:904,411...912,172
Ensembl chr18:904,871...912,172
G
ATF2
activating transcription factor 2
ISO
RGD
PMID:9813301
RGD:10047413
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:19922414
RGD:6892922
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CD59
CD59 molecule (CD59 blood group)
ISO
mRNA, protein:increased expression:facial VII nucleus
RGD
PMID:9846834
RGD:1600495
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CLU
clusterin
ISO
protein:increased expression:neuron,astrocyte
RGD
PMID:10800205
RGD:408418725
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CSF1
colony stimulating factor 1
ISO
protein:increased expression:facial VII nerve, microglial cell
RGD
PMID:20831658
RGD:5131509
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
G
CTSS
cathepsin S
ISO
RGD
PMID:17539023
RGD:5686912
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
G
GFRA1
GDNF family receptor alpha 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
G
HGF
hepatocyte growth factor
treatment
ISO
RGD
PMID:21562589
RGD:8548634
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
MT3
metallothionein 3
treatment
ISO
RGD
PMID:14625437
RGD:9685806
NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088
G
NDUFA5
NADH:ubiquinone oxidoreductase subunit A5
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:8875451
RGD:2302319
NCBI chr 7:123,536,997...123,601,651
Ensembl chr 7:123,536,997...123,557,904
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr10:43,077,069...43,130,351
Ensembl chr10:43,077,064...43,130,351
G
ACVR1B
activin A receptor type 1B
ISO
RGD
PMID:9013782
RGD:151665480
NCBI chr12:51,951,699...51,997,078
Ensembl chr12:51,951,699...51,997,078
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409
G
AIF1
allograft inflammatory factor 1
ISO
RGD
PMID:9698327
RGD:704401
NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021
G
CSNK2B
casein kinase 2 beta
ISO
RGD
PMID:11068334
RGD:11565824
NCBI chr 6:31,666,080...31,670,067
Ensembl chr 6:31,665,227...31,670,343
G
FGF2
fibroblast growth factor 2
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
G
GFRA1
GDNF family receptor alpha 1
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
G
IL1R1
interleukin 1 receptor type 1
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
G
MCAM
melanoma cell adhesion molecule
ISO
RGD
PMID:10076889
RGD:7364787
NCBI chr11:119,308,529...119,317,130
Ensembl chr11:119,308,529...119,321,521
G
MME
membrane metalloendopeptidase
ISO
RGD
PMID:8201016
RGD:13801045
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr 1:84,078,079...84,238,498
Ensembl chr 1:84,078,062...84,238,498
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr10:43,077,069...43,130,351
Ensembl chr10:43,077,064...43,130,351
G
SMAD1
SMAD family member 1
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176
G
SMAD2
SMAD family member 2
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
G
SMAD3
SMAD family member 3
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SMAD4
SMAD family member 4
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
G
SMAD7
SMAD family member 7
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:48,919,853...48,950,965
Ensembl chr18:48,919,853...48,950,965
G
SMAD9
SMAD family member 9
ISO
mRNA:decreased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr13:36,844,831...36,920,854
Ensembl chr13:36,844,831...36,920,887
G
TXNRD1
thioredoxin reductase 1
ISO
mRNA, protein:increased expression:neuron
RGD
PMID:19833109
RGD:5133729
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
GP6
glycoprotein VI platelet
exacerbates
ISO
RGD
PMID:21258336
RGD:401824683
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
MDM2
MDM2 proto-oncogene
treatment
ISO
RGD
PMID:34334113
RGD:155882538
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
ZEB2
zinc finger E-box binding homeobox 2
treatment
ISO
protein:increased expression:brain (rat)
RGD
PMID:34334113 PMID:34334113
RGD:155882538 , RGD:155882538
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
ISO
mRNA:decreased expression:bone
RGD
PMID:19607804
RGD:5147852
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
G
IHH
Indian hedgehog signaling molecule
ISO
RGD
PMID:23992905
RGD:12911207
NCBI chr 2:219,054,424...219,060,921
Ensembl chr 2:219,054,424...219,060,921
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:motor neuron
RGD
PMID:21456016
RGD:5684341
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
ADCY10
adenylate cyclase 10
ISO
protein:decreased expression:retina
RGD
PMID:22649251
RGD:329347828
NCBI chr 1:167,809,386...167,914,134
Ensembl chr 1:167,809,386...167,914,215
G
ADNP
activity dependent neuroprotector homeobox
ISO
RGD
PMID:18414890
RGD:2312783
NCBI chr20:50,888,918...50,931,437
Ensembl chr20:50,888,916...50,931,437
G
AMIGO3
adhesion molecule with Ig like domain 3
treatment
ISO
RGD
PMID:23613963
RGD:14390159
NCBI chr 3:49,716,829...49,719,684
Ensembl chr 3:49,716,829...49,719,684
G
AQP4
aquaporin 4
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
AQP9
aquaporin 9
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
G
ARG2
arginase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30618589
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ATF2
activating transcription factor 2
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
G
BAX
BCL2 associated X, apoptosis regulator
ISO
mRNA:increased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
ISO
mRNA:decreased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BDNF
brain derived neurotrophic factor
treatment
IDA ISO
RGD
PMID:15140649 PMID:9520478 PMID:11050383
RGD:8655584 , RGD:8655637 , RGD:8655586
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
C3
complement C3
ISO
mRNA:increased expression:optic nerve
RGD
PMID:14577867
RGD:5129542
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CDK2
cyclin dependent kinase 2
ISO
mRNA:increased expression:retina
RGD
PMID:16723461
RGD:2293567
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:27443501
RGD:11568693
NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
G
CLU
clusterin
ISO
RGD
PMID:14577867
RGD:5129542
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CSF1R
colony stimulating factor 1 receptor
ISO
mRNA:increased expression:retina (rat)
RGD
PMID:20187850
RGD:151665810
NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372
G
CSF3
colony stimulating factor 3
treatment
IDA
RGD
PMID:20144610
RGD:11039471
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CTSB
cathepsin B
ISO
protein:increased expression:retina (rat)
RGD
PMID:18775855
RGD:2315508
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
EDN1
endothelin 1
ISO
protein:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EDNRA
endothelin receptor type A
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
G
EDNRB
endothelin receptor type B
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr13:77,895,487...77,975,527
Ensembl chr13:77,895,481...77,975,529
G
EP300
E1A binding protein p300
ISO IMP
protein:decreased expression:retinal ganglion cell layer (rat) human gene in rat model
RGD
PMID:21705428 PMID:21705428
RGD:7349392 , RGD:7349392
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
G
FGF2
fibroblast growth factor 2
treatment
IMP
RGD
PMID:14664816
RGD:8554854
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:increased expression:retina
RGD
PMID:33664770
RGD:329951020
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
GDNF
glial cell derived neurotrophic factor
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GFRA1
GDNF family receptor alpha 1
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
G
GFRA2
GDNF family receptor alpha 2
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr 8:21,690,398...21,812,345
Ensembl chr 8:21,690,398...21,812,357
G
HGF
hepatocyte growth factor
treatment
IDA
RGD
PMID:21443522
RGD:8548549
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein: altered activity: eye protein:increased expression:retina:
RGD
PMID:19484445 PMID:23648097
RGD:5686431 , RGD:10046025
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr 1:160,037,467...160,070,160
Ensembl chr 1:159,998,651...160,070,483
G
MT-CO1
mitochondrially encoded cytochrome c oxidase I
ISO
mRNA:increased expression:retina
RGD
PMID:12076086
RGD:8662362
NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
G
MYRF
myelin regulatory factor
ISO
mRNA:decreased expression: oligodendrocyte
RGD
PMID:29915135
RGD:213230153
NCBI chr11:61,752,636...61,788,518
Ensembl chr11:61,752,636...61,788,518
G
NAMPT
nicotinamide phosphoribosyltransferase
treatment
ISO
RGD
PMID:28032230
RGD:13781885
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NCAM1
neural cell adhesion molecule 1
ISO
RGD
PMID:18757519
RGD:2326023
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NEFM
neurofilament medium chain
ISO
RGD
PMID:8501527
RGD:9743936
NCBI chr 8:24,913,761...24,919,093
Ensembl chr 8:24,913,758...24,919,098
G
NEO1
neogenin 1
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr15:73,051,692...73,305,206
Ensembl chr15:73,051,710...73,305,205
G
NGF
nerve growth factor
ISO
protein:increased expression:retina
RGD
PMID:28067793
RGD:402463954
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NGFR
nerve growth factor receptor
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
G
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:20357199 PMID:34245756
RGD:5684908 , RGD:597015764
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA:increased expression:retina:
RGD
PMID:12836167
RGD:1299297
NCBI chr12:79,584,879...79,690,964
Ensembl chr12:79,574,979...79,690,964
G
PAX6
paired box 6
ISO
protein:increased expression:retina (rat)
RGD
PMID:23297010
RGD:8552379
NCBI chr11:31,789,026...31,817,961
Ensembl chr11:31,784,779...31,817,961
G
PDGFB
platelet derived growth factor subunit B
ISO
protein:decreased expression:nerve fiber:
RGD
PMID:9893812
RGD:10449496
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:optic nerve (rat)
RGD
PMID:22336118
RGD:6767293
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PLAU
plasminogen activator, urokinase
ISO
mRNA:increased expression:optic nerve (rat)
RGD
PMID:20798533
RGD:6483802
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PTPN5
protein tyrosine phosphatase non-receptor type 5
ISO
protein:increased expression:retina (rat)
RGD
PMID:15555919
RGD:9835027
NCBI chr11:18,727,928...18,792,721
Ensembl chr11:18,727,928...18,792,721
G
RHOA
ras homolog family member A
ISO
protein:increased expression, altered localization:retina
RGD
PMID:17534117
RGD:1642826
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
SNW1
SNW domain containing 1
ISO
protein:increased expression:retina (rat)
RGD
PMID:25074585
RGD:11035254
NCBI chr14:77,717,599...77,761,156
Ensembl chr14:77,717,599...77,761,207
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:19661221
RGD:597538516
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
TLR4
toll like receptor 4
ISO
protein:increased expression:optic nerve
RGD
PMID:23103505
RGD:7794777
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
RGD
PMID:18552980 PMID:14697498
RGD:7794683 , RGD:8661743
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TRADD
TNFRSF1A associated via death domain
ISO
protein:increased expression: retina
RGD
PMID:18552980
RGD:7794683
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
G
YBX3
Y-box binding protein 3
ISO
mRNA:increased expression:retinal ganglion cell
RGD
PMID:11750989
RGD:2311250
NCBI chr12:10,699,089...10,723,323
Ensembl chr12:10,699,089...10,723,323
G
FGF2
fibroblast growth factor 2
ISO
mRNA:increased expression:retina
RGD
PMID:9268592
RGD:8655567
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
NEO1
neogenin 1
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr15:73,051,692...73,305,206
Ensembl chr15:73,051,710...73,305,205
G
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr15:93,035,271...93,089,211
Ensembl chr15:93,035,271...93,089,211
G
ENTPD1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
protein:increased expression,increased activity:cerebral cortex:
RGD
PMID:16672190
RGD:9685448
NCBI chr10:95,694,186...95,877,266
Ensembl chr10:95,711,779...95,877,266
G
FGFR1
fibroblast growth factor receptor 1
ISO
mRNA,protein:increased expression:astrocyte,macrophage,neutrophil:
RGD
PMID:11168551
RGD:10402049
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
G
GFAP
glial fibrillary acidic protein
ISO
RGD
PMID:10225952
RGD:6480471
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
G
PDGFB
platelet derived growth factor subunit B
ISO
protein:increased expression:neuron:
RGD
PMID:7526956
RGD:10449485
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
VIM
vimentin
ISO
RGD
PMID:10225952
RGD:6480471
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
TRH
thyrotropin releasing hormone
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:8690305
NCBI chr 3:129,974,720...129,977,935
Ensembl chr 3:129,974,688...129,977,935
G
BMP4
bone morphogenetic protein 4
treatment
IDA
RGD
PMID:16332232
RGD:8699514
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
IGF1
insulin like growth factor 1
IEP
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
PLAT
plasminogen activator, tissue type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:1899364
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
ADAM10
ADAM metallopeptidase domain 10
ISO
RGD
PMID:22489706
RGD:13703033
NCBI chr15:58,588,809...58,749,707
Ensembl chr15:58,588,809...58,749,791
G
AHR
aryl hydrocarbon receptor
ISO
protein:increased expression:T cell, neuron, brain cortex, hippocampus
RGD
PMID:27506546
RGD:405878081
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
APP
amyloid beta precursor protein
treatment
IDA
RGD
PMID:29320530
RGD:13782048
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:24582457
RGD:13782254
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BDNF
brain derived neurotrophic factor
ISO
mRNA:increased expression:CA3 field of hippocampus, dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BID
BH3 interacting domain death agonist
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:632018 , RGD:5509821
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
G
CAPN1
calpain 1
severity
ISO
protein:increased expression:cytosol, plasma membrane
RGD
PMID:9469158 PMID:15307896
RGD:13792664 , RGD:5509821
NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006
G
CAPN2
calpain 2
severity
ISO
RGD
PMID:9469158 PMID:15307896
RGD:13792664 , RGD:5509821
NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018
G
CASP3
caspase 3
severity
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125 PMID:15307896
RGD:329961568 , RGD:5509821
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP8
caspase 8
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:632018 , RGD:5509821
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:632018 , RGD:5509821
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CCNG1
cyclin G1
treatment
ISO
RGD
PMID:24398934 PMID:18612315
RGD:151356934 , RGD:151356935
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,448,199
G
CD163
CD163 molecule
ISO
protein:increased expression:brain, macrophage (rat)
RGD
PMID:22583855
RGD:127285798
NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
G
CD8A
CD8 subunit alpha
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:31383034
RGD:124715446
NCBI chr 2:86,784,605...86,808,396
Ensembl chr 2:86,784,610...86,808,396
G
CIT
citron rho-interacting serine/threonine kinase
ISO
mRNA:decreased expression:cerebral cortex��(rat)
RGD
PMID:12503083
RGD:2317873
NCBI chr12:119,685,791...119,877,320
Ensembl chr12:119,685,791...119,877,320
G
CTNNB1
catenin beta 1
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CXCL10
C-X-C motif chemokine ligand 10
treatment
ISO
RGD
PMID:26435412
RGD:27095897
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)
treatment
ISO
RGD
PMID:26068867
RGD:401901590
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
DRD1
dopamine receptor D1
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
G
DRD2
dopamine receptor D2
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
FUBP1
far upstream element binding protein 1
ISO
RGD
PMID:23797733
RGD:13673879
NCBI chr 1:77,944,055...77,979,501
Ensembl chr 1:77,944,055...77,979,110
G
GNAL
G protein subunit alpha L
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr18:11,689,264...11,885,685
Ensembl chr18:11,689,264...11,885,685
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ISO
protein:increased phosphorylation:central amygdaloid nucleus (rat)
RGD
PMID:30638118
RGD:405101698
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
G
ICAM1
intercellular adhesion molecule 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IL1B
interleukin 1 beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
ITGB1
integrin subunit beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
G
LAMA1
laminin subunit alpha 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr18:6,941,742...7,117,797
Ensembl chr18:6,941,742...7,117,797
G
LAMP2
lysosomal associated membrane protein 2
ISO
protein:increased expression:hippocampus:
RGD
PMID:28365875
RGD:13703062
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
G
LCN2
lipocalin 2
ISO
RGD
PMID:31539545
RGD:126781751
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:28412141 PMID:25771151 PMID:26484783 PMID:26729399
RGD:13800902 , RGD:13800917 , RGD:13800912 , RGD:13800909
NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 4:118,685,392...118,715,430
Ensembl chr 4:118,685,392...118,715,433
G
MIR155
microRNA 155
ISO
RGD
PMID:28804446
RGD:25314324
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MMP2
matrix metallopeptidase 2
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
NCSTN
nicastrin
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr 1:160,343,383...160,358,949
Ensembl chr 1:160,343,294...160,358,952
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
protein:increased expression:brain:
RGD
PMID:30855558
RGD:26884463
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NGF
nerve growth factor
treatment
ISO
RGD
PMID:26285082
RGD:402463964
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NMNAT1
nicotinamide nucleotide adenylyltransferase 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr 1:9,942,923...9,996,892
Ensembl chr 1:9,943,428...9,985,501
G
NOS2
nitric oxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOX1
NADPH oxidase 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr X:100,843,324...100,874,359
Ensembl chr X:100,843,324...100,874,359
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
protein:increased phosphorylation:amygdala mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:30638118 PMID:36637480
RGD:405101698 , RGD:408364984
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
OCLN
occludin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
PARP1
poly(ADP-ribose) polymerase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829224 PMID:28642177
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PDE10A
phosphodiesterase 10A
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr 6:165,327,289...165,988,052
Ensembl chr 6:165,327,287...165,988,117
G
PDYN
prodynorphin
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12626770
RGD:633616
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
PHACTR1
phosphatase and actin regulator 1
treatment
ISO
RGD
PMID:36571365
RGD:401901253
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PPP3R1
protein phosphatase 3 regulatory subunit B, alpha
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr 2:68,178,857...68,252,532
Ensembl chr 2:68,178,857...68,256,237
G
PPP3R2
protein phosphatase 3 regulatory subunit B, beta
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr 9:101,591,604...101,594,969
Ensembl chr 9:101,591,604...101,595,021
G
PSEN1
presenilin 1
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr14:73,136,417...73,223,691
Ensembl chr14:73,136,418...73,223,691
G
PTGS2
prostaglandin-endoperoxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RELA
RELA proto-oncogene, NF-kB subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593 PMID:28642177
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SOX2
SRY-box transcription factor 2
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr 3:181,711,925...181,714,436
Ensembl chr 3:181,711,925...181,714,436
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:28433746
RGD:14995478
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TP53
tumor protein p53
treatment
ISO
RGD
PMID:27553877
RGD:14995939
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
UBE4B
ubiquitination factor E4B
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr 1:10,032,958...10,181,239
Ensembl chr 1:10,032,832...10,181,239
G
WNT3A
Wnt family member 3A
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr 1:228,006,998...228,061,271
Ensembl chr 1:228,006,998...228,061,271
G
F7
coagulation factor VII
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20370756
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
ABCC8
ATP binding cassette subfamily C member 8
treatment
ISO
RGD
PMID:18854840
RGD:2325137
NCBI chr11:17,392,498...17,476,845
Ensembl chr11:17,392,498...17,476,894
G
TP53
tumor protein p53
ISO
RGD
PMID:22977862
RGD:8547771
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
ADRB2
adrenoceptor beta 2
ISO
mRNA:increased expression:Vestibulocochlear nerve:
RGD
PMID:22178544
RGD:8548530
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all